August 14, 2026 7:12AM

Dermocosmetics in Malaysia: How Consumers Choose Clinical Skincare

Malaysia’s skincare market is becoming more sophisticated as consumers pay closer attention not only to what a product promises, but also to whether those promises feel credible. Skin suitability remains central to product choice, but safety, dermatologist endorsement, reliable results and brand trust are also important signals when Malaysians decide what deserves a place in their skincare routine.

This creates an important competitive space for dermocosmetics, which our Malaysia Skincare Study 2026 defines as science led, sensitive skin and clinically positioned skincare. The study tracks 11 brands within this segment: Cetaphil, Eucerin, CeraVe, Bioderma, Neutrogena, La Roche Posay, Avene, Sebamed, Physiogel, Vichy and A-Derma.

Yet clinical credentials alone do not determine which brands consumers prefer or recommend. Science can provide reassurance and help a brand enter consideration, but once consumers compare credible alternatives, trust, proven results and value become increasingly important. The real competition in dermocosmetics is therefore not simply about which brand appears most clinical, but which one can translate scientific credibility into an experience consumers understand, trust and consider worth recommending.

Key Insights

• Clinical reassurance matters. 39% consider dermatological testing important, while 48% say dermatologist recommendation influences brand choice.
• Trust and safety are fundamental. 65% prioritise safe, high quality products and 61% look for a brand they trust.
• Scale does not guarantee advocacy. Cetaphil leads on reach and preference, while CeraVe generates the strongest recommendation.
• Results, trust and value drive recommendation. Among CeraVe promoters, 68% cite effectiveness, while 66% cite value and brand trust.

Research Methodology

This article is based on findings from the Malaysia Skincare Study 2026 conducted by Vodus Research. The study explored how Malaysians use skincare, the concerns and benefits that shape their choices, their skincare routines, purchase behaviour, brand preferences and attitudes towards different skincare products and brands.

The survey collected responses from 2,221 Malaysian adult skincare users across Peninsular and East Malaysia, spanning different age groups, income levels, ethnic backgrounds, regions and skincare user types. Respondents were asked about their skincare habits, skin concerns, product preferences, purchase behaviour and perceptions of brands and country of origin. Fieldwork was conducted from 28 May to 15 June 2026.

Insights were gathered through Vodus Research’s proprietary OMTOS online survey method, which reaches Malaysian consumers through the Vodus Media Network. The research approach uses Vodus’s media partner network, including Astro and Media Prima, to reach consumers at scale.

Clinical Reassurance Is Becoming Part of the Skincare Decision

The appeal of dermocosmetics becomes clearer when we look at what Malaysians consider important when choosing skincare. Suitability for skin type is the leading product consideration in our study, but consumers are also looking for reassurance that products are dermatologically tested, gentle on the skin and capable of producing visible results. This suggests that many skincare decisions are increasingly about reducing uncertainty: consumers want to know whether a product is appropriate for their skin and whether there is a credible reason to believe it will work.

At brand level, the same pattern is even more pronounced. 65% of Malaysian skincare users say safe and high quality products influence which brand they choose, while 61% look for a brand they trust. Dermatologist recommendation and consistent results each influence 48%. Positive reviews, products designed for different skin concerns and transparency around ingredients also contribute to the reassurance consumers seek.

There are also differences across consumer groups. Older and middle to higher income consumers place greater emphasis on brand trust, dermatologist endorsement and reliable results when choosing skincare brands. For dermocosmetic brands, this suggests that clinical reassurance does not carry exactly the same weight for every audience, and the role of proof can vary depending on life stage and spending power.

For dermocosmetic brands, this creates an advantage but also a challenge. Dermatological testing, ingredient expertise and clinically positioned claims can reduce perceived risk, but consumers still need to understand what that science means for their own skin. A clinical claim becomes more persuasive when it connects clearly to a concern, a result or reassurance that the product can be used comfortably and consistently.

Dermocosmetics Are Serving More Than Sensitive Skin

Dermocosmetics are often associated mainly with sensitive skin, but our consumer data shows a much broader competitive landscape. The brands measured attract different age groups, skincare mindsets and consumer needs, indicating that clinically positioned skincare is not serving one homogeneous audience.

Cetaphil and Eucerin have the largest usage footprints among the leading brands measured. Cetaphil has particular strength among adults aged 25 to 34 and skincare enthusiasts, while CeraVe has a younger profile. Neutrogena attracts a somewhat older and more affluent audience and shows stronger relevance among age defying skincare users.

Some smaller competitors occupy more specific audience niches. Bioderma, for example, shows relatively greater strength among men and East Coast consumers. These patterns illustrate why it is too simplistic to think of the dermocosmetic audience as a single group of consumers seeking “clinical skincare."

A younger consumer dealing with acne, sensitivity or skin barrier concerns may approach the segment very differently from an older consumer focused on ageing, while another consumer may primarily want a gentle formulation that reduces the risk of irritation. What connects these different needs is a desire for greater confidence, but the underlying problem each consumer expects the brand to solve can vary considerably.

The full Malaysia Skincare Study 2026 provides a deeper view of these differences, including brand profiles across age, region, income, ethnicity, skin type and skincare persona. This allows individual dermocosmetic brands to be understood not only by how many consumers use them, but also by the types of consumers behind that usage.

Cetaphil Leads Reach, but Brand Strength Takes Different Forms

Cetaphil holds the broadest position within the dermocosmetic competitive landscape measured in our study, leading awareness, current usage, consideration and first preference. Eucerin maintains a substantial presence of its own, giving both brands strong visibility throughout the consumer funnel.

However, looking only at reach would miss an important part of the competitive story. CeraVe converts a particularly high share of people who have previously used the brand into current users, despite having a smaller overall footprint than Cetaphil and Eucerin. This shows that attracting consumers, retaining them after trial and becoming their preferred brand are related but distinct measures of performance.

That distinction matters in a segment where many competitors can credibly speak about science, sensitive skin and dermatological expertise. Large brands benefit from familiarity and an established user base, but smaller brands can still build a strong position if consumers who try them find the experience compelling enough to continue using them.

The audience behind each brand also differs beyond simple age profiles. The full report breaks dermocosmetic usage down further by region, income, ethnicity, skin type and skincare persona, helping show where individual brands have stronger consumer footholds and where their audiences differ from the category overall.

CeraVe Shows Why Advocacy Can Outrun Scale

Recommendation produces a different competitive picture from usage. CeraVe generates the strongest recommendation within the dermocosmetic set despite ranking behind Cetaphil and Eucerin in current usage. Cetaphil and Neutrogena also generate strong advocacy, while Eucerin’s sizeable user base does not translate into the same level of recommendation.

This reinforces an important distinction between being widely used and being strongly recommended. Usage can reflect familiarity, availability, established routines or previous trial. Recommendation requires something more: consumers have to believe their experience was positive enough that they would advocate for the brand to another person.

The reasons CeraVe promoters give provide useful insight into what can drive that advocacy. 68% cite effective products as a reason for recommending CeraVe, while 66% point to good value for money and 66% to trusted brand reputation.

These findings bring together three dimensions of dermocosmetic success. The product has to work, the brand has to feel trustworthy and what the consumer receives has to feel worth the price. Scientific credentials can create confidence before purchase, but the actual product experience determines whether that confidence remains after use.

Trust, Results and Value Shape Dermocosmetic Preference

The deeper brand analysis in our study supports the same conclusion. Within the dermocosmetic competitive set, brand trust is the strongest driver of preference, followed by reliable results and value for money. Other attributes, including products addressing specific skin concerns, ingredient transparency, high quality ingredients and dermatological testing, also contribute to brand perceptions.

Interestingly, gentleness ranks lower as a differentiator within the segment. This should not be interpreted as consumers no longer caring about gentle formulations. A more plausible explanation from the analysis is that consumers already expect dermocosmetic brands to be relatively mild and skin friendly, which reduces the ability of gentleness alone to distinguish one competitor from another.

The same dynamic can develop around other clinical cues. As more brands credibly communicate dermatological testing, sensitive skin suitability, active ingredients or skin barrier expertise, these claims can gradually become expected characteristics of the category rather than compelling reasons to choose one brand.

This is why the competitive formula for dermocosmetics differs from other parts of skincare. Across our wider analysis, mass and mainstream brands are influenced particularly by product feel and efficacy, while Asian masstige brands compete through a combination of product experience, efficacy and personal fit. Within dermocosmetics, trust, results and value become especially important.

Clinical Credibility Is the Foundation, Not the Whole Brand

The brand imagery analysis provides another indication of how competitive dermocosmetics have become. Several leading brands already perform strongly on characteristics consumers would expect from clinical skincare, including effectiveness, ingredient quality, gentleness and trust. Broad claims around being scientific or clinically positioned therefore do not automatically give a brand a distinctive identity.

CeraVe records broad perceptual strength across areas including trust, ingredient quality, gentleness and personal relevance. Eucerin and Sebamed show stronger credentials around transparency, while Cetaphil and Sebamed have particular strength around perceived effectiveness.

Other competitors stand apart through narrower associations. Neutrogena is more differentiated around value, while CeraVe and Cetaphil stand out around personal relevance and Avene around trust. The broader finding is that distinctiveness comes increasingly from focused strengths rather than broad clinical claims shared by much of the category.

The findings therefore show that dermocosmetic brands are not perceived as interchangeable simply because they operate within the same clinical space. Consumers are forming more specific associations around value, trust, transparency, effectiveness and personal relevance, creating different competitive positions even among brands that share similar scientific credentials.

Science Does Not Remove Price Sensitivity

Consumers may be willing to pay for specialist formulations and stronger reassurance, but clinical positioning does not remove price sensitivity. Across several dermocosmetic brands evaluated in the study, perceived overpricing repeatedly appears among the leading reasons consumers give for dissatisfaction. Limited product ranges and irritation concerns also create friction for selected brands.

This matters because value is not only a source of dissatisfaction. It is also one of the stronger drivers of dermocosmetic preference. Consumers may accept that clinical expertise, specialist formulations or extensive product development can support a higher price, but those credentials do not provide unlimited pricing power. The consumer still needs to believe the benefit justifies what is being charged.

Value within dermocosmetics therefore should not be understood simply as being inexpensive. A consumer may perceive value through dependable results, a formulation they trust enough to repurchase or a product that addresses a specific concern successfully enough to justify its price. This explains why price and efficacy can sit alongside each other rather than operating as opposing considerations.

Expert Validation and Consumer Proof Work Together

Dermatologist endorsement is only one source of reassurance. When Malaysians decide whether to try a new skincare product, 61% say positive expert reviews or recommendations encourage trial, while 71% point to positive consumer reviews or recommendations. Discounts and free samples also help consumers act, while new launches or trends alone are substantially less influential.

For dermocosmetics, this creates an interesting relationship between professional expertise and consumer experience. Dermatologists and other credible experts can provide reassurance around ingredients, skin suitability and expected performance, while consumer reviews help potential users understand how those claims translate into everyday use.

The two sources of reassurance therefore play complementary roles. Clinical expertise can help establish why a product deserves consideration, while consumer experience provides another layer of evidence about whether that promise holds up in practice. In a category where consumers may be dealing with specific or persistent skin concerns, both forms of proof can be relevant to the decision.

Clinical Skincare Principles Are Influencing the Wider Market

The significance of dermocosmetics extends beyond brands traditionally classified within the segment. Across the wider Malaysia Skincare Study 2026, safety, trust, dermatologist recommendation, consistent results and ingredient transparency all feature in broader skincare brand choice.

This suggests that some expectations commonly associated with clinical skincare now matter across the wider category. Consumers are not necessarily looking only for a product that appears dermatological; they are looking for clearer evidence behind claims, stronger reassurance around formulations and a credible link between what a product promises and the skin concern it is designed to address.

At the same time, established dermocosmetic brands operate in a market where consumers can compare different brands, origins and price tiers against similar needs. A brand may possess strong clinical credentials but still face competition from alternatives that consumers perceive as more relevant, more trusted or better value.

Dermocosmetics Are Part of a Wider Shift in Malaysian Skincare

The growing relevance of clinical reassurance is only one part of a broader change in how Malaysians approach skincare. Consumers are becoming more selective about the products they use, comparing brands across different origins and price tiers while paying closer attention to formulation, specific skin needs, value and credible proof.

Dermocosmetics sit within this wider market alongside established mass brands and a growing range of Asian masstige options, giving consumers more ways to address the same underlying skincare needs. To see how these shifts fit into the broader category, read our Malaysia Skincare Market Trends 2026: What Brands Need to Know, which examines changing consumer needs, routines, purchasing behaviour, product choice and the wider competitive landscape.

The Future of Dermocosmetics Is About Proving the Promise

Dermocosmetics occupy an important position in Malaysia because they answer a fundamental consumer need: confidence. People want greater confidence that the skincare they use is appropriate for their skin, supported by credible evidence and capable of delivering a meaningful result.

But our findings show that science is only the starting point. Cetaphil demonstrates the advantage of broad reach and preference, while CeraVe shows how a smaller footprint can translate into particularly strong advocacy. Other competitors establish different strengths around effectiveness, transparency, value, trust or personal relevance.

The competitive picture is therefore becoming more nuanced. Different brands are succeeding for different reasons, and the factors that shape preference can vary substantially across consumer groups and individual competitors. Understanding those differences requires looking beyond topline performance into brand funnels, audience profiles, recommendation, choice drivers and detailed brand perceptions.

The public findings above highlight some of the major patterns, while the full Malaysia Skincare Study 2026 provides the deeper demographic and competitive context behind them, including age, income, region, ethnicity, skin type and skincare persona profiles for individual brands.

What’s Inside the Full Malaysia Skincare Study 2026?

The findings above highlight some of the forces shaping dermocosmetics and clinical skincare, but the full Malaysia Skincare Study 2026 provides the detailed consumer and brand level analysis needed to understand where individual competitors are strong and where opportunities differ across audiences.

The full report includes:

• Awareness, past usage and current usage across tracked skincare brands
• Future consideration and brand preference
• Full brand funnel and conversion analysis
• Recommendation and advocacy results
• Demographic, skin type and skincare persona profiles behind leading brands
• Reasons for satisfaction and dissatisfaction by brand
• The attributes that drive brand choice within each competitive segment
• Detailed brand imagery and perception scores
• Areas where individual brands stand apart from their competitive set
• Comparative analysis across mass and mainstream, Asian masstige and dermocosmetic brands
• Complete brand level percentages and competitive benchmarks

Want to understand how Malaysia’s leading dermocosmetic brands compare? Download the full Malaysia Skincare Study 2026 to access the detailed brand rankings, audience profiles, perception scores and competitive analysis.

Vodus Research pioneered the OMTOS survey method to deliver accurate, fast and affordable market research in Malaysia, supported by actionable consumer, brand and industry insights. Our research solutions include brand health tracking, product innovation research, target market research, customer satisfaction surveys and advertising research, helping organisations understand consumer behaviour, evaluate brand performance, identify market opportunities, improve customer experience and strengthen marketing effectiveness.

To learn how Vodus can help your organisation uncover opportunities and make more informed business and marketing decisions, contact us at contact@vodus.com.